Last reviewed · How we verify

NCT05959915: CLARITY

ECG Monitoring Short vs Middle Term After Atrial Fibrillation Ablation

Completed Last updated 10 July 2025
What this trial tests

trial testing device e-patch Implantation in Atrial Fibrillation in 96 participants. Completed in 1 June 2025.

Timeline
1 July 2023
Primary endpoint
1 July 2024
1 June 2025

Quick facts

Lead sponsorHospital Clinic of Barcelona
StatusCompleted
Study typeOBSERVATIONAL
Enrollment96
Start date1 July 2023
Primary completion1 July 2024
Estimated completion1 June 2025
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Clinic of Barcelona

Who can join

Adults 18 to 99, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the number of patients with AF recurrence detected in a 24-h Holter monitoring with a 5-day record.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Hospital Clinic of Barcelona trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05959915.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing